Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

People with albinism often have poor vision. A new study from the Netherlands Institute for Neuroscience reveals the underlying cause. In Europe, albinism occurs in 1 in 20,000 individuals. However, in some populations, it is much more common, affecting 1…

In children with amblyopia, often referred to as “lazy eye,” one eye exhibits weaker vision than the other due to various factors. This weaker eye may struggle with focusing, misalignment due to strabismus, or vision obstruction from conditions like cataracts…

Toku announced the acquisition of the CE Mark in Europe and UKCA certification in the United Kingdom for its patented CLAiR technology. This innovation offers a non-invasive method for assessing the risk of cardiovascular disease (CVD) directly at the point…

According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.1 The study’s lead author is Panagiotis Laspas, MD, of the Department of…

Nocturnal lagophthalmos is the inability to close the eyelids while sleeping. This can result in a range of conditions from mild epithelial changes to severe exposure ulcers (Katz and Kaufman, 1977). Lagophthalmos is associated with exposure keratopathy, poor sleep, and…

Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS). Dr. Sanders holds the distinction of…

In the realm of refractive surgery, individuals seeking visual freedom are presented with a plethora of options. Two prominent procedures, SMILE (Small Incision Lenticule Extraction) and LASIK (Laser-Assisted In Situ Keratomileusis), have emerged as front-runners, each with its unique benefits…

Formosa Pharmaceuticals announced a strategic licensing agreement with Cristália Produtos Químicos Farmacêuticos to secure exclusive commercialization rights for APP13007 (clobetasol propionate ophthalmic nanosuspension, 0.05%) in Brazil. APP13007 is designed for the treatment of inflammation and pain following ocular surgery and…

Allotex and SpA have announced the successful completion of the first close of their $30 million Series B financing. The funds raised will be utilized to further develop their technology aimed at treating refractive errors. The decision to invest in…

Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…